Abstract
Menstrual Toxic Shock Syndrome (mTSS) stands as a rare yet potentially life-threatening condition, characterized by a cascade of systemic effects resulting from the release of toxic shock syndrome toxin-1 (TSST-1) and other superantigens during menstruation. This article aims to provide an in-depth analysis of the pathophysiological mechanisms underlying mTSS, elucidate the diverse array of risk factors contributing to its development, and present contemporary strategies for the management and prevention of this enigmatic syndrome. By synthesizing current research findings and clinical insights, this comprehensive review seeks to enhance our understanding of mTSS, fostering improved diagnostic precision and optimizing patient outcomes.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
